4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
Chronic Traumatic Encephalopathy
Samuel GandySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Chronic Traumatic Encephalopathy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
[18F]Flornaptitril CereMark Pharma, LLC | Phase 3 | B |
FLORTAUCIPIR Samuel Gandy | Phase 2 | B |
Marijuana OMNI Medical Services, LLC | Phase 2 | CCC |
Same molecule, other indications
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →